Implantable devices to monitor patients with heart failure.
Nikolaos KaramichalakisJohn ParissisGeorge BakosisVasiliki BistolaIgnatios IkonomidisAntonios SiderisGerasimos FilippatosPublished in: Heart failure reviews (2019)
Reducing heart failure hospitalizations represents a major challenge for modern clinicians. Early detection of congestion plays a key role in disease management strategy. Apart from traditional methods (patient reporting symptoms, body weight monitoring), novel home-care strategies allow guided adjustments in medical therapy through telemonitoring embedded in cardiac electronic implantable devices or through stand-alone diagnostic devices for hemodynamic monitoring. Wireless pulmonary artery pressure monitoring seems to reduce re-admission risk and is currently approved for this purpose in patients with heart failure. Multiparameter monitoring is also appealing and could be a valuable tool in managing these patients. However, invasive techniques face several safety concerns and cost-effectiveness issues. Therefore, quest for future research and emerging technologies is necessary.
Keyphrases
- pulmonary artery
- body weight
- heart failure
- end stage renal disease
- pulmonary hypertension
- coronary artery
- healthcare
- pulmonary arterial hypertension
- ejection fraction
- left ventricular
- chronic kidney disease
- emergency department
- palliative care
- peritoneal dialysis
- stem cells
- prognostic factors
- case report
- atrial fibrillation
- mesenchymal stem cells
- physical activity
- cardiac resynchronization therapy
- drug administration